BXL-62

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBXL-62
Drug Alias NameBXL-62
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D3 analogues
TargetsVitamin D receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioxell Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioxell Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A